Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.

Conditions

• Cancer

Sponsor

Assistance Publique Hopitaux De Marseille